Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys? — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys? — Stella

Recruiting

Back to Kidney Transplant; Complications trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Norway

Oslo University Hospital, Oslo, Oslo

Key details

Phase

Post-approval study

Sponsor

Oslo University Hospital

Collaborators

St. Olavs Hospital, University Hospital of North Norway

Enrollment target

~330 participants

Started

May 2023

Primary completion

June 2028

Age range

18 Years – 75 Years

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov